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ABSTRACT 
 
Objective To assess the awareness and acceptability of pre-exposure prophylaxis 
(PrEP) among men who have sex with men (MSM) and use sociosexual media at high 
risk of HIV infection in four Celtic nations. 
 
Design Cross-sectional study 
 
Methods Online self-complete survey of 386 HIV-negative/status unknown MSM 
who reported condomless anal intercourse (CAI) with e2 men in the last year, 
recruited from gay sociosexual media. 
 
Results One third (34.5% 132/386) of participants were aware of PrEP but over half 
(58.5%, 226/356) reported they would be willing to use PrEP if it were available to 
them. Only men who regularly tested for HIV every 6 months (AOR 2.89, 95% CI 
1.54-5.42) were more likely to be aware of PrEP. PrEP acceptability was only 
associated with reporting e5 CAI partners (OR 2.04, 95% CI 1.2-3.46) in the last 
year. 
 
Conclusions Low levels of PrEP awareness were reported across these Celtic nations. 
Only one third of high risk MSM had heard of PrEP but over one half would be 
willing to take a daily pill to prevent HIV infection. Sociodemographic factors, 
commercial gay scene proximity, and social network use were unrelated to 
considering PrEP use. However those reporting most CAI partners were more likely 
to consider PrEP use.  
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Towards preparedness for PrEP. PrEP awareness and acceptability amongst MSM at 
high risk of HIV transmission in four Celtic nations - Scotland, Wales, Northern 
Ireland and the Republic of Ireland: An online survey 
 
INTRODUCTION 
 
Pre-Exposure Prophylaxis (PrEP) is the use of anti-retroviral medication by HIV 
negative individuals before HIV exposure to prevent infection. The recent UK 
PROUD1 and French Ipergay2 studies found that PrEP (tenofovir/emtricitabine) 
reduced HIV infection by 86% amongst men who have sex with men (MSM) at high 
risk of HIV infection, in a real-world setting. The unprecedented clinical efficacy of 
PrEP within these studies3 coupled with widespread media interest4 in this biomedical 
intervention has reinvigorated debates around PrEP availability in the UK and 
elsewhere.  
 
MSM remain at disproportionate risk for HIV infection within the UK5 and Republic 
of Ireland (RoI).6 Current evidence suggests that PrEP may reduce HIV transmission 
amongst MSM by up to 86%.1, 2 Since the initial clinical trials documenting PrEP 
success,7 a growing international literature has charted the association of PrEP 
awareness and acceptability amongst MSM,8, 9 building an albeit limited population 
level understanding of PrEP. Unsurprisingly, there is emerging consensus that PrEP is 
most likely to be used by those who engage in high risk behaviour8-12 rather than any 
other indicative sociodemographic markers.8, 9 Complementary cost efficacy analysis 
also suggests that PrEP should be promoted to high risk MSM.13 Thus, there is a clear 
need to understand preparedness for PrEP amongst the most likely beneficiaries: 
MSM at high risk of HIV transmission.  
 
The SMMASH (Social Media, MSM and Sexual Health) cross-sectional survey 
collected information about social media use, sexual health and behaviours amongst 
men recruited online in four Celtic nations; Scotland, Wales, Northern Ireland (NI) 
and RoI. Using data from 2013, we explored the characteristics of high risk MSM, to 
determine; 
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1) Which factors are associated with PrEP awareness amongst high risk MSM? 
2) Which factors are associated with PrEP acceptability amongst high risk MSM? 
 
METHODS 
The SMMASH Survey (see supplementary data for a copy) collected anonymous, 
online self-complete questionnaires with MSM in Scotland, Wales, NI and RoI. 
Participants were recruited from the most popular UK/Irish gay-specific social media 
websites (Gaydar, Recon and Squirt), smartphone apps (Grindr and Gaydar) and 
Facebook between November 2012 and February 2013 using banner advertising and 
direct message ‘blasts’. Full details of the survey were provided to participants on the 
landing webpage, highlighting they were under no obligation to take part and 
participation taken as evidence of informed consent. No financial participation 
incentive was given. Participants were asked not to complete the questionnaire if they 
had already done so but duplicates were not screened for. In total 2280 men 
completed useable questionnaires, but given the nature of online recruitment 
advertising and men’s multiple profiles/use of multiple sites it is not possible to 
calculate a response rate. Questionnaires surveyed sociodemographics, sexual health 
and sexual behaviours in the previous 12 months. 
 
The following description of PrEP was provided: “A drug (called Truvada) has been 
licensed in America to reduce the risk of sexually acquiring HIV for people who are 
HIV negative. This is known as Pre-Exposure Prophylaxis (PrEP prophylaxis just 
means ‘prevention’). In order for the drug to work properly, it needs to be taken once 
a day and never missed. It can reduce the chance of HIV infection for men who have 
sex with men by 73%1 if taken every day. It doesn’t have any serious side effects but it 
can cause nausea in the first month for about 10% of people who take it. The drug is 
not yet available in the UK.” PrEP awareness was assessed by asking whether 
participants had previously heard of PrEP (Response: Yes, No/Unsure). PrEP 
acceptability was assessed by asking ‘If this PrEP pill were available today, how 
likely would you be to use it?’ (Response: 7 point Likert Scale from Extremely Likely                                                         1 This figure was accurate at the time of data collection and was taken from Grant R.M, Lama JR, Anderson PL, et al. 
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. N Engl J Med 2010;363:2587–
2599. 
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to Extremely Unlikely, collapsed into a dichotomous variable; likely vs 
unsure/unlikely). In addition, a definition of post-exposure prophylaxis (PEP) was 
also included, to avoid confusion between the two. 
Data Analysis 
Data were analysed with IBM SPSS 22. Overall, 129 (5.7%) participants were HIV 
positive and 2151 (94.3%) were HIV-negative or status unknown. Men who were 
HIV-positive were excluded from this analysis because personal PrEP use is only 
applicable to men who are HIV-negative. Analysis focused on the 462 HIV-
negative/status unknown participants (21.5%) who reported CAI with e2 men in the 
last year and as such were defined as ‘high risk men’. We adopted the term CAI 
herein, rather than the more usual ‘unprotected anal intercourse’ since condomless 
anal intercourse with PrEP use constitutes protected sex in terms of HIV transmission. 
Men with missing data on any of the variables in the final regression models were 
excluded from each analysis, leaving a total of n=356 men for PrEP awareness and 
n=386 for PrEP acceptability (see Figure 1). Chi-square tests were used for bivariate 
comparisons. Variables significant at the bivariate level (p<0.05) were entered into 
two multivariate logistic regression models (using the default Forced Entry Method) 
used to estimate odds ratios (OR) and 95% confidence intervals (CI) for PrEP 
awareness and acceptability.  
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Figure 1 Flow of participants through the study 
 
 
RESULTS 
Respondent Characteristics 
HIV-negative/status unknown high risk men (n=386) were drawn from Scotland 
(44%, n=170), Wales (22%, n=85), the RoI (19.9%, n=73) and NI (14%, n=54), 
largely reflecting the relative population sizes of those countries (with Scotland over- 
(+7%) and RoI underrepresented (-9.5%)). Over half were recruited from Gaydar 
(56.5%, n=215), with Grindr (19.9%, n=77), Facebook (13.5%, n= 52), Squirt (9.6%, 
n=37) provided most remaining participants; only 5 (0.5%) were recruited from 
Recon. Most (83.4%, n=322) said they were HIV-negative whilst 16.6% (n=64) said 
they were unsure. Mean age was 37 years (sd=12.9, range 18 – 82), most (98.2%, 
n=379) were white and over two-thirds (n=244) had degree level education. Two 
thirds (n=256) were single, 27.3% (n=105) reported a regular male partner/civil 
partnership and 6% (n=23) a regular female partner. Most participants used gay social 
media at least daily (63.5%, n=245) and infrequently went out on the commercial gay 
scene, leading us to collapse the latter into a dichotomous measure of either Never 
(35.4%, n=136) or Ever (64.6%, n=248). A majority were open about their sexual 
orientation to nearly everyone (64.2%, n=248), and just under half (46%, n=168) said 
that their nearest commercial gay scene was not within easy reach. In terms of sexual 
health self monitoring, over half reported a recent HIV (59.0%, n=162) or STI 
(54.5%, n=210) test, one third (28.4%, n=106) regularly test for HIV at least every 6 
months and half (52.1%, n=201) regularly test for other STIs at least annually. Most 
reported more than 10 male sex partners (64.5%, n=249), half reported more than 10 
male anal partners (44.8%, n=173) and almost one third reported 5 or more male CAI 
partners (28.5%, n=110). These data, as well as a breakdown of these variables by 
country are provided in a supplementary online appendix. 
 
PrEP awareness and acceptability amongst high risk HIV-negative/status 
unknown MSM 
Only one third (34.5%, n=132) of participants had heard of PrEP prior to completing 
the survey. However, over half (58.5%, n=226) said they were likely to use daily 
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PrEP if it were available today, with 20.2% (n=78) unsure and 21.2% (n=82) unlikely 
to use PrEP. 
 
Factors associated with PrEP Awareness amongst high risk HIV-negative/status 
unknown MSM 
Table 1 shows the Chi2 and regression analyses for factors associated with PrEP 
awareness. Participants were more likely to be aware of PrEP if they lived in NI 
(compared to Wales or RoI), reported frequent (daily or more often) gay social media 
use, lived near the commercial gay scene, reported an HIV test or an STI test in the 
last year, reported regular HIV testing at least every 6 months or regular STI testing at 
least every year. In the multivariate regression model, only regular (at least every 6 
months) HIV testing remained independently associated with PrEP awareness 
(adjusted OR 2.89, 95% CI 1.54-5.42). 
 
 
Table 1 Associations between demographics, sexual behaviours and service use and 
PrEP awareness among n=356 high risk HIV negative/status unknown MSM 
 
 
Characteristic 
% (n/N) heard of 
PrEP Chi2 sig value 
 
OR (95% CI) 
 
AOR (95% CI) 
Age 
18-25 
26-35 
36-45 
45+ 
 
 
32.1 (26/81)NS 
38.6 (34/88) 
37.2 (29/28) 
32.1 (35/109) 
 
1 (p=0.713) 
1.33 (0.71-2.51) 
1.25 (0.65-2.41) 
1 (0.54-1.85) 
 
Employment status  
Employed / self-employed 
Unemployed 
Retired / DLA / carer 
Student  
 
 
37.1 (93/251)NS 
18.9 (7/37) 
22.2 (4/18) 
38.8 (19/49) 
 
1 (p=0.112) 
0.40 (0.17-0.94) 
0.49 (0.16-1.52) 
1.08 (0.57-2.02) 
 
Country  
Northern Ireland 
Scotland 
Wales 
Republic of Ireland 
 
52.1(25/48)* 
36.6 (56/153) 
28.0 (23/82) 
27.4 (20/73) 
 
 
1 (p=0.022) 
0.53 (0.28-1.02) 
0.36 (0.17-0.75) 
0.35 (0.16-0.75) 
 
 
1 (p=0.056) 
0.52 (0.26-1.06) 
0.39 (0.17-0.87) 
0.35 (0.15-0.79) 
Educational qualification 
Secondary / none 
Further / vocational 
Degree / postgraduate 
 
 
25.6 (10/39)NS 
32.9 (25/76) 
36.5 (84/230) 
 
1 (p=0.399) 
1.42 (0.6-3.37) 
1.67 (0.78-3.59) 
 
Relationship status 
Single 
Regular male partner 
Regular female partner 
 
 
35.0 (82/234)NS 
37.4 (37/99) 
20.0 (4/20) 
 
1 (p=0.345) 
1.11 (0.68-1.18) 
0.46 (0.15-1.43) 
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Frequency of gay social media use 
Less than daily 
Daily of more often 
 
27.4 (34/126)* 
39.1 (90/230) 
 
 
1 (p=0.022) 
1.74 (1.08-2.80) 
 
1(p=0.077) 
1.59 (0.95-2.66) 
Frequency of gay scene use 
Never use gay scene 
Ever use gay scene 
 
 
30.2 (35/116)NS 
37.0 (88/238) 
 
1 (p=0.208) 
1.36 (0.84-2.19) 
 
How out  
Not very out 
Out to nearly everyone 
 
 
29.5 (36/122)NS 
37.6 (88/234) 
 
1 (p=0.129) 
1.44 (0.9-2.31) 
 
Perceived proximity to commercial gay 
scene 
Far from gay scene  
Near gay scene 
 
 
29.1 (48/165)* 
39.8 (76/191) 
 
 
1 (p=0.035) 
1.61 (1.03-2.51) 
 
1 (p=0.138) 
1.45 (0.89-2.36) 
Self-reported HIV status 
Negative  
Unknown 
 
 
36.7 (108/294)NS 
25.8 (16/62) 
 
1 (p=0.103) 
0.6 (0.32-1.11) 
 
Recent HIV Test 
Never or > 1 year ago 
d 1 year ago 
 
 
21.2 (31/146)** 
44.3 (93/210) 
 
1 (p<0.001) 
2.95 (1.82-4.77) 
 
1 (p=0.539) 
1.27 (0.59-2.77) 
Recent STI test 
Never or > 1 year ago 
d 1 year ago 
 
 
23.5 (38/86)** 
44.3 (86/194) 
 
 
1 (p<0.001) 
2.60 (1.64-4.12) 
 
1 (p=0.84) 
1.09 (0.48-2.47) 
Regular HIV test 
Never or less frequently than every 6 months 
At least every 6 months 
 
 
24.4 (61/250)** 
59.4 (63/106) 
 
 
1(p<0.001) 
4.54 (2.80-7.36) 
 
1 (p=0.001) 
2.89 (1.54-5.42) 
Regular STI testing 
Never or less frequently than yearly 
Yearly or more often 
 
 
23.3 (42/180)** 
46.6 (82/176) 
 
1(p<0.001) 
2.87 (1.82-2.52) 
 
1 (p=0.497) 
1.26 (0.62-2.65) 
Number of sex partners 
<10 partners 
10+ partners 
 
 
33.1(41/124)NS 
35.8 (83/232) 
 
1 (p=0.609) 
1.13 (0.71-1.79) 
 
Number of anal sex partners 
<10 anal partners 
10+ anal partners 
 
 
32.1 (62/193)NS 
38.0 (62/163) 
 
1 (p=0.244) 
1.3 (0.84-2.01) 
 
Number of CAI partners  
2-4 CAI partners 
e5 CAI partners 
 
 
32.8 (83/253)NS 
39.8 (41/103) 
 
1 (p=0.210) 
1.35 (0.84-2.18) 
 
NSnot significant, *p<0.05, **p<0.001 
 
 
Factors associated with PrEP acceptability amongst high risk HIV-
negative/status unknown MSM 
Table 2 shows the Chi2 and regression analyses for factors associated with PrEP 
acceptability. Reporting e10 anal and e5 CAI partners in the last year significantly 
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increased participants’ odds of reporting they were likely to use PrEP if it were 
available today. Having previously heard of PrEP was not associated with PrEP 
acceptability. In the multivariate model only reporting e5 CAI partners remained 
independently associated with PrEP acceptability (OR=2.04, 95% CI 1.2-3.46). 
 
Table 2 Associations between HIV status, sexual behaviours and service use and 
PrEP acceptability among n=386 high risk HIV negative/status unknown MSM 
 
 
Characteristic 
% (n/N) Likely to use 
PrEP Chi2 sig value 
 
OR (95% CI) 
 
AOR (95% CI) 
Age 
Age 18-25 
Age 26-35 
Age 36-45 
Age 45+ 
 
 
59.3 (54/91)NS 
62.9 (61/97) 
53.6 (45/84) 
57.9 (66/114) 
 
1 (p=0.649) 
1.16 (0.65-2.09) 
0.79 (0.43-1.44) 
0.94 (0.54-1.65) 
 
Employment status  
Employed / self-employed 
Unemployed 
Retired / DLA / carer 
Student  
 
 
58.6 (160/273)NS 
59.0 (23/39) 
60.0 (12/20) 
56.6 (30/53) 
 
1 (p=0.992) 
1.02 (0.51-2.01) 
1.06 (0.42-2.66) 
0.21 (0.51-1.67) 
 
Country  
Northern Ireland 
Scotland 
Wales 
Republic of Ireland 
 
 
59.3 (32/54)NS 
55.9 (95/170) 
64.7 (55/85) 
57.1 (44/77) 
 
1 (p=0.595) 
0.87 (0.47-1.62) 
1.26 (0.63-2.54) 
0.92 (0.45-1.86) 
 
 
Educational qualification 
Secondary / none 
Further / vocational 
Degree / postgrad uate 
 
 
60.0 (27/45)NS 
58.3 (49/84) 
59.0 (144/244) 
  
1(p=0.983) 
0.93 (0.45-1.96) 
0.96 (0.5-1.84) 
 
Relationship status 
Single 
Regular male partner 
Regular female partner 
 
 
61.7 (158/256)NS 
51.4 (54/105) 
56.5 (13/23) 
 
1 (p=0.194) 
0.66 (0.42-1.04) 
0.81 (0.34-1.91) 
 
Frequency of gay social media use 
Less than daily 
Daily or more often 
 
 
53.2 (75/141) NS 
61.6 (151/245) 
 
1 (p=0.106) 
1.41 (0.93-2.15) 
 
Frequency of gay scene use 
Never use gay scene 
Ever use gay scene 
 
 
58.1 (79/136) NS 
58.9 (146/248) 
 
1 (p=0.882) 
1.03 (0.68-1.58) 
 
How out  
Not very out 
Out to nearly everyone 
 
 
52.9 (73/138) NS 
61.7 (153/248) 
 
1 (p=0.093) 
1.43 (0.94-2.19) 
 
Perceived proximity to commercial gay 
scene 
Far from gay scene  
Near gay scene 
 
 
 
61.9 (104/168) NS 
54.8 (108/197) 
 
 
1 (p=0.172) 
0.75 (0.49-1.14) 
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Self-reported HIV status 
Negative  
Unknown  
 
 
56.5 (182/322) NS 
68.8 (44/64) 
 
1 (p=0.072) 
1.69 (0.96-3) 
 
 
Recent HIV test 
Never or > 1 year ago 
Recent d 1 year ago 
 
 
62.3 (101/162) NS 
55.8 (125/224) 
 
1 (p=0.198) 
0.76 (0.51-1.15) 
 
Recent STI test 
Never or > 1 year ago 
Recent d 1 year ago 
 
 
60.2 (106/176) NS 
57.1 (120/210) 
 
1 (p=0.54) 
0.88 (0.59-1.32) 
 
Regular HIV test 
Never or less frequently than every 6 months 
Every 6 months or more often 
 
 
58.4 (156/267) NS 
60.4 (64/106) 
 
1 (p=0.73) 
1.08 (0.69-1.72) 
 
Regular STI testing 
Never or less frequently than yearly 
Yearly or more often 
 
 
59.7 (120/201) NS 
57.3 (106/185) 
 
1 (p=0.632) 
0.91 (0.6-1.36) 
 
Number of sex partners 
<10 partners 
10+ partners 
 
 
52.6 (72/137) NS 
61.8 (154/249) 
 
1 (p=0.077) 
1.46 (0.96-2.23) 
 
 
Number of anal sex partners 
<10 anal partners 
10+ anal partners 
 
 
53.5 (114/213)* 
64.7 (112/173) 
 
1 (p=0.026) 
1.59 (1.06-2.41)  
 
1 (p=0.431) 
1.2 (0.76-1.91) 
Number of CAI partners  
2-4 CAI partners 
e5 CAI partners 
 
 
53.3 (147/276)* 
71.8 (79/110) 
 
1 (p=0.001) 
2.24 (1.39-3.61)  
 
1 (p=0.008) 
2.04 (1.2-3.46) 
Heard of PrEP 
Yes 
No/Unsure 
 
 
60.6 (80/132)NS 
57.4 (144/251) 
 
1 (p=0.541) 
0.88 (0.57-1.34) 
 
NSnot significant, *p<0.05. 
 
 
DISCUSSION 
Principal Findings 
Only one third of high risk HIV-negative/status unknown men recruited online in the 
four Celtic nations of Scotland, Wales, NI and RoI had previously heard of PrEP. 
Awareness was patterned by country, social media use, commercial gay scene 
proximity and involvement in HIV/STI testing behaviours, suggesting an inequity of 
information provision and sexual health service, patterned by key routes of MSM 
sexual health promotion. However, over half of men said they would be willing to use 
PrEP. PrEP acceptability was associated with higher numbers of anal and CAI sex 
partners even amongst this high risk group, but not by PrEP awareness or 
sociodemographic factors. These findings suggest that HIV negative/status unknown 
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MSM at high risk of HIV may be willing to use PrEP to reduce their risk of HIV 
infection. Therefore, a key imperative for HIV prevention is to ensure high risk men 
are appropriately targeted for PrEP use. It is important to note that the definition of 
high risk sex (CAI with e2 partners in the last year) used herein, does not constitute 
higher risk of HIV infection in the context of correct PrEP use, which itself provides 
around 86% reduction in HIV transmission, although little protection against other 
STIs.3 As such, our findings suggest that those men who already engage in high levels 
of condomless sex are the most willing to adopt a biomedical HIV risk reduction 
strategy alternative to condoms. These findings suggest that if these men were to 
access PrEP there is considerable potential for the reduction of onwards transmission 
of HIV. 
 
Comparison with other studies 
Levels of PrEP awareness amongst high risk MSM in the four Celtic nations were 
somewhat higher than the 11-23% reported amongst the wider population of MSM8, 9 
though similar to more recently published work in western countries12, 14-16 reiterating 
the expected increase over time already documented.15 Although substantial variation 
within countries has been observed (e.g. Thailand 66%,17 7%;10 China 11%,18 22%19) 
the almost 2-fold difference between RoI and NI suggests investigation of local health 
promotion initiatives into new HIV prevention technologies is warranted. Across the 
literature, multiple variables are associated with PrEP awareness amongst western 
MSM, including increased age,12, 20 higher education16, 20 and recent HIV/STI 
testing12, 16 although no consistent patterns have emerged. Certainly, this relationship 
between HIV/STI testing resonated with our results, suggesting a higher level of 
sexual health self monitoring, or sexual health literacy, amongst the PrEP aware. 
However, no previous studies have examined the relationship between PrEP 
awareness and either social media use or commercial gay scene proximity. Thus our 
study is the first to suggest a link between PrEP awareness and proximity to key 
health promotion mediums, including sexual health services, commercial gay scene 
and social media. These key findings should be addressed within future intervention 
development.  
 
Candidacy for PrEP remains a key question. Amongst high risk MSM, PrEP 
acceptability was related to neither sociodemographics nor PrEP awareness. This 
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reinforces the finding that, for this subgroup at least, only additional high risk sex 
increases the likelihood of PrEP acceptability. Previous PrEP investigations of high 
risk MSM have included substance use in their high risk definition,21, 22 or unorthodox 
definitions of high risk23 so their results do not directly transfer to MSM with high 
sexual behaviour risk. Moreover, since the PROUD study3 included only men who 
reported and anticipated some CAI (within 90 days prior to and following 
recruitment), our study results are more relevant to this population than other PrEP 
awareness papers. 
 
Strengths and weaknesses 
This paper examines PrEP awareness and acceptability amongst high risk MSM; 
those who are most likely to benefit from, or indeed be offered, PrEP. A clear 
definition of PrEP was provided to participants, as has been recommended,8 detailing 
efficacy, potential side effects and the importance of high adherence. Although our 
definition did not clarify that this efficacy level required high adherence24, subsequent 
evidence now suggests that PrEP is more efficacious with less stringent adherence3, 25 
than was specified herein, which may increase MSM’s willingness to use this 
biotechnology as an HIV prevention tool. The on-going scientific debates about 
efficacy and adherence complicate how PrEP is explained to potential users. A 
limitation of this study - and most other PrEP studies - is the uncertainty of what is 
clinically accurate relating to PrEP regimens. Our findings, therefore, will be affected 
by wider issues in the field relating to data on how most recent clinical findings are 
translated into guidelines and practice. 
 
Additionally, a contrasting definition of PEP was also provided (see supplementary 
data), to avoid potential confusion between the two, to further improve questionnaire 
validity. Economic aspects of PrEP were not addressed within this study. 
Internationally the cost of PrEP is prohibitive to population level uptake and 
provision. There is a danger that these economic factors may amplify health 
inequalities; affluent men may purchase PrEP and reduce their risks of infection 
whilst these risks will remain for those who cannot afford or access PrEP because of 
reduced material and/or psychosocial resources. Within national contexts that offer 
health care and prevention it may be cost effective to offer PrEP to those at highest 
risk with greatest vulnerability to HIV infection. 
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Although high risk is defined herein as condomless anal intercourse with e2 partners, 
data were not gathered to exclude those practising treatment-as-prevention (TasP) 
from this definition. However, evidence suggests that, at the time of data collection, 
there was ‘very limited knowledge of TasP as a prevention strategy’ (p.2),26 TasP 
awareness was limited to people in close proximity to HIV, largely MSM diagnosed 
with HIV [ibid], and no public health campaigns to date have focused on TasP within 
these nations. Since then current BHIVA guidelines suggested TasP as a prevention 
strategy on a case-by-case basis, in concert, this failure to assess TasP should not 
dramatically impact study validity. 
 
Recruiting participants online, albeit via the principal social and sociosexual media 
used by gay men, entails that a convenience sample is generated since a response rate 
cannot be generated, questioning representativeness and limiting generalizability to 
only those MSM who use sociosexual media. Herein, the overall sample size is 
relatively modest, in particular when broken down by individual countries. However, 
these data are drawn from the largest PrEP acceptability study outwith North America 
to date and encompass 4 countries, including large cities, semi-urban and rural 
populations. These populations are usually overlooked by traditional recruitment 
methods. Yet whilst the approach adopted here is more inclusive with regards to 
geographic reach, it may also exclude those men who may lack the material and/or 
psychosocial resources to utilise the sociosexual media. Critically, these men may 
well be the most vulnerable to sexual ill health. Finally, online sampling prevented 
HIV status verification via linked oral testing herein, as used in several commercial 
gay scene studies.27, 28 However, the rate of undiagnosed positive men was only 1.3–
1.8% in those studies,27, 28. 
 
Implications 
In announcing the highest PrEP protection rate of any trials to date, the PROUD1 and 
Ipergay2 study results necessitate an urgent consideration of NHS PrEP treatment 
policy. Our data (collected prior to the PROUD/Ipergay announcement) suggest 
widespread interest in PrEP use by high risk MSM – the same group involved in these 
studies - but also that many men who may benefit from PrEP are currently unaware of 
it. Therefore, there is a need for diverse means of raising PrEP awareness should it 
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ever be available within the UK/Ireland, including both mass media and social 
marketing approaches.29 However, the observed differences in PrEP awareness by 
region, engagement with health services, social media use and proximity to the 
commercial gay scene demand a targeted and tailored approach to raise PrEP 
awareness amongst this group of men. Principles such as targeted audience 
segmentation within social marketing30 may be critical in reaching those men who 
cannot be characterised as having high levels of sexual health service literacy. In 
recruiting participants online, most of whom infrequently used the commercial gay 
scene, this study emphasises the importance of online health promotion, particularly 
via social media, to reach men who standard sexual health promotion and services 
delivered via commercial and community gay venues may exclude. Finally, even 
within this sample of high risk men, it is those who are at the highest risk that are 
most willing to use PrEP. As such, focused risk assessment tools, delivered online, 
may be beneficial to further explore PrEP candidacy amongst HIV-negative MSM at 
the highest risk of HIV infection. 
 
Key Messages 
• Only one third of high risk MSM had heard of PrEP but over half found PrEP 
for HIV acceptable. 
• Sexual health self monitoring was related to increased awareness of PrEP. 
• Men reporting the most CAI and anal partners were more likely to consider 
PrEP, but sociodemographics, commercial gay scene proximity and social networking 
were unrelated. 
• Targeted health promotion, capitalising on social marketing and audience 
segmentation, should include an online component, delivered via social media. 
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